Antibiotic efficacy — context matters

Current Opinion in Microbiology

Volumn 39, Issue , 2017, Pages 73-80

  Yang, Jason H ^a,b   Bening, Sarah C ^a,b   Collins, James J ^a,b,c  

^a Massachusetts Institute of Technology   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; OXYGEN; REACTIVE OXYGEN METABOLITE; ANTIINFECTIVE AGENT;

BACTERIAL METABOLISM; BACTERICIDAL ACTIVITY; CELL DEATH; CELL RESPIRATION; DNA DAMAGE; DRUG EFFICACY; ENVIRONMENTAL FACTOR; EXTRACELLULAR MATRIX; NONHUMAN; REDOX STRESS; REVIEW; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM; BIOLOGICAL MODEL; DRUG EFFECTS; ENVIRONMENT; MICROBIAL VIABILITY;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; ENVIRONMENT; MICROBIAL VIABILITY; MODELS, BIOLOGICAL; OXYGEN;

EID: 85031736743     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2017.09.002     Document Type: Review

References (117)

1. Kohanski, M.A., Dwyer, D.J., Collins, J.J., How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 8 (2010), 423–435.
2. Dwyer, D.J., Collins, J.J., Walker, G.C., Unraveling the physiological complexities of antibiotic lethality. Annu Rev Pharmacol Toxicol 55 (2015), 313–332.
3. Brown, E.D., Wright, G.D., Antibacterial drug discovery in the resistance era. Nature 529 (2016), 336–343.
4. Fridman, O., Goldberg, A., Ronin, I., Shoresh, N., Balaban, N.Q., Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. Nature 513 (2014), 418–421.
5. Van den Bergh, B., Michiels, J.E., Michiels, J., Experimental evolution of Escherichia coli persister levels using cyclic antibiotic treatments. Methods Mol Biol 1333 (2016), 131–143.
6. Gomez, J.E., Kaufmann-Malaga, B.B., Wivagg, C.N., Kim, P.B., Silvis, M.R., Renedo, N., Ioerger, T.R., Ahmad, R., Livny, J., Fishbein, S., et al. Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment. Elife, 6, 2017.
7. Kohanski, M.A., DePristo, M.A., Collins, J.J., Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell 37 (2010), 311–320.
8. Nguyen, D., Joshi-Datar, A., Lepine, F., Bauerle, E., Olakanmi, O., Beer, K., McKay, G., Siehnel, R., Schafhauser, J., Wang, Y., et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334 (2011), 982–986.
9. Rueda, J., Realpe, T., Mejia, G.I., Zapata, E., Rozo, J.C., Ferro, B.E., Robledo, J., Genotypic analysis of genes associated with independent resistance and cross-resistance to isoniazid and ethionamide in Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother 59 (2015), 7805–7810.
10. Jia, B., Raphenya, A.R., Alcock, B., Waglechner, N., Guo, P., Tsang, K.K., Lago, B.A., Dave, B.M., Pereira, S., Sharma, A.N., et al. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res 45 (2017), D566–D573.
11. Kohanski, M.A., Dwyer, D.J., Hayete, B., Lawrence, C.A., Collins, J.J., A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130 (2007), 797–810.
12. Kohanski, M.A., Dwyer, D.J., Wierzbowski, J., Cottarel, G., Collins, J.J., Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135 (2008), 679–690.
13. Yeom, J., Imlay, J.A., Park, W., Iron homeostasis affects antibiotic-mediated cell death in Pseudomonas species. J Biol Chem 285 (2010), 22689–22695.
14. Frawley, E.R., Crouch, M.L., Bingham-Ramos, L.K., Robbins, H.F., Wang, W., Wright, G.D., Fang, F.C., Iron and citrate export by a major facilitator superfamily pump regulates metabolism and stress resistance in Salmonella Typhimurium. Proc Natl Acad Sci U S A 110 (2013), 12054–12059.
15. Mehi, O., Bogos, B., Csorgo, B., Pal, F., Nyerges, A., Papp, B., Pal, C., Perturbation of iron homeostasis promotes the evolution of antibiotic resistance. Mol Biol Evol 31 (2014), 2793–2804.
16. Foti, J.J., Devadoss, B., Winkler, J.A., Collins, J.J., Walker, G.C., Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics. Science 336 (2012), 315–319.
17. Kottur, J., Nair, D.T., Reactive oxygen species play an important role in the bactericidal activity of quinolone antibiotics. Angew Chem Int Ed Engl 55 (2016), 2397–2400.
18. Bizzini, A., Zhao, C., Auffray, Y., Hartke, A., The Enterococcus faecalis superoxide dismutase is essential for its tolerance to vancomycin and penicillin. J Antimicrob Chemother 64 (2009), 1196–1202.
19. Gusarov, I., Shatalin, K., Starodubtseva, M., Nudler, E., Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 325 (2009), 1380–1384.
20. Wang, X., Zhao, X., Malik, M., Drlica, K., Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell death. J Antimicrob Chemother 65 (2010), 520–524.
21. Shatalin, K., Shatalina, E., Mironov, A., Nudler, E., H2S: a universal defense against antibiotics in bacteria. Science 334 (2011), 986–990.
22. Ling, J., Cho, C., Guo, L.T., Aerni, H.R., Rinehart, J., Soll, D., Protein aggregation caused by aminoglycoside action is prevented by a hydrogen peroxide scavenger. Mol Cell 48 (2012), 713–722.
23. Mosel, M., Li, L., Drlica, K., Zhao, X., Superoxide-mediated protection of Escherichia coli from antimicrobials. Antimicrob Agents Chemother 57 (2013), 5755–5759.
24. Liu, Y., Imlay, J.A., Cell death from antibiotics without the involvement of reactive oxygen species. Science 339 (2013), 1210–1213.
25. Keren, I., Wu, Y., Inocencio, J., Mulcahy, L.R., Lewis, K., Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339 (2013), 1213–1216.
26. Ezraty, B., Vergnes, A., Banzhaf, M., Duverger, Y., Huguenot, A., Brochado, A.R., Su, S.Y., Espinosa, L., Loiseau, L., Py, B., et al. Fe–S cluster biosynthesis controls uptake of aminoglycosides in a ROS-less death pathway. Science 340 (2013), 1583–1587.
27. Van Acker, H., Coenye, T., The role of reactive oxygen species in antibiotic-mediated killing of bacteria. Trends Microbiol 25 (2017), 456–466.
28. Zhao, X., Hong, Y., Drlica, K., Moving forward with reactive oxygen species involvement in antimicrobial lethality. J Antimicrob Chemother 70 (2015), 639–642.
29. Belenky, P., Ye, J.D., Porter, C.B., Cohen, N.R., Lobritz, M.A., Ferrante, T., Jain, S., Korry, B.J., Schwarz, E.G., Walker, G.C., et al. Bactericidal antibiotics induce toxic metabolic perturbations that lead to cellular damage. Cell Rep 13 (2015), 968–980.
30. Hoerr, V., Duggan, G.E., Zbytnuik, L., Poon, K.K., Grosse, C., Neugebauer, U., Methling, K., Loffler, B., Vogel, H.J., Characterization and prediction of the mechanism of action of antibiotics through NMR metabolomics. BMC Microbiol, 16, 2016, 82.
31. Zampieri, M., Zimmermann, M., Claassen, M., Sauer, U., Nontargeted metabolomics reveals the multilevel response to antibiotic perturbations. Cell Rep 19 (2017), 1214–1228.
32. Maglica, Z., Ozdemir, E., McKinney, J.D., Single-cell tracking reveals antibiotic-induced changes in mycobacterial energy metabolism. MBio, 6, 2015 e02236-02214 This paper demonstrates that antibiotic treatment significantly alters single-cell energy production using microfluidics and an intracellular ATP biosensor.
33. Dwyer, D.J., Belenky, P.A., Yang, J.H., MacDonald, I.C., Martell, J.D., Takahashi, N., Chan, C.T., Lobritz, M.A., Braff, D., Schwarz, E.G., et al. Antibiotics induce redox-related physiological alterations as part of their lethality. Proc Natl Acad Sci U S A 111 (2014), E2100–E2109.
34. Lobritz, M.A., Belenky, P., Porter, C.B., Gutierrez, A., Yang, J.H., Schwarz, E.G., Dwyer, D.J., Khalil, A.S., Collins, J.J., Antibiotic efficacy is linked to bacterial cellular respiration. Proc Natl Acad Sci U S A 112 (2015), 8173–8180.
35. Lamprecht, D.A., Finin, P.M., Rahman, M.A., Cumming, B.M., Russell, S.L., Jonnala, S.R., Adamson, J.H., Steyn, A.J., Turning the respiratory flexibility of Mycobacterium tuberculosis against itself. Nat Commun, 7, 2016, 12393.
36. Liu, X., Marrakchi, M., Jahne, M., Rogers, S., Andreescu, S., Real-time investigation of antibiotics-induced oxidative stress and superoxide release in bacteria using an electrochemical biosensor. Free Radic Biol Med 91 (2016), 25–33.
37. Meylan, S., Porter, C.B., Yang, J.H., Belenky, P., Gutierrez, A., Lobritz, M.A., Park, J., Kim, S.H., Moskowitz, S.M., Collins, J.J., Carbon sources tune antibiotic susceptibility in Pseudomonas aeruginosa via tricarboxylic acid cycle control. Cell Chem Biol 24 (2017), 195–206.
38. Nandakumar, M., Nathan, C., Rhee, K.Y., Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nat Commun, 5, 2014, 4306.
39. Vilcheze, C., Hartman, T., Weinrick, B., Jacobs, W.R. Jr., Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction. Nat Commun, 4, 2013, 1881.
40. Thomas, V.C., Kinkead, L.C., Janssen, A., Schaeffer, C.R., Woods, K.M., Lindgren, J.K., Peaster, J.M., Chaudhari, S.S., Sadykov, M., Jones, J., et al. A dysfunctional tricarboxylic acid cycle enhances fitness of Staphylococcus epidermidis during beta-lactam stress. MBio, 4, 2013.
41. Brynildsen, M.P., Winkler, J.A., Spina, C.S., MacDonald, I.C., Collins, J.J., Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production. Nat Biotechnol 31 (2013), 160–165.
42. Grant, S.S., Kaufmann, B.B., Chand, N.S., Haseley, N., Hung, D.T., Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals. Proc Natl Acad Sci U S A 109 (2012), 12147–12152.
43. Tkachenko, A.G., Akhova, A.V., Shumkov, M.S., Nesterova, L.Y., Polyamines reduce oxidative stress in Escherichia coli cells exposed to bactericidal antibiotics. Res Microbiol 163 (2012), 83–91.
44. Duan, X., Huang, X., Wang, X., Yan, S., Guo, S., Abdalla, A.E., Huang, C., Xie, J., L-Serine potentiates fluoroquinolone activity against Escherichia coli by enhancing endogenous reactive oxygen species production. J Antimicrob Chemother 71 (2016), 2192–2199.
45. Goswami, M., Mangoli, S.H., Jawali, N., Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli. Antimicrob Agents Chemother 50 (2006), 949–954.
46. Maitra, A., Dill, K.A., Bacterial growth laws reflect the evolutionary importance of energy efficiency. Proc Natl Acad Sci U S A 112 (2015), 406–411.
47. Hui, S., Silverman, J.M., Chen, S.S., Erickson, D.W., Basan, M., Wang, J., Hwa, T., Williamson, J.R., Quantitative proteomic analysis reveals a simple strategy of global resource allocation in bacteria. Mol Syst Biol, 11, 2015, 784.
48. Cho, H., Uehara, T., Bernhardt, T.G., Beta-lactam antibiotics induce a lethal malfunctioning of the bacterial cell wall synthesis machinery. Cell 159 (2014), 1300–1311.
49. •] demonstrated futile cycling of peptidoglycan precursors in response to different β-lactam antibiotics, carefully applying antibiotics to probe aspects of cell physiology.
50. Hards, K., Robson, J.R., Berney, M., Shaw, L., Bald, D., Koul, A., Andries, K., Cook, G.M., Bactericidal mode of action of bedaquiline. J Antimicrob Chemother 70 (2015), 2028–2037.
51. Rao, S.P., Alonso, S., Rand, L., Dick, T., Pethe, K., The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 105 (2008), 11945–11950.
52. Mok, W.W., Park, J.O., Rabinowitz, J.D., Brynildsen, M.P., RNA futile cycling in model persisters derived from MazF accumulation. MBio, 6, 2015 e01588-01515.
53. Adolfsen, K.J., Brynildsen, M.P., Futile cycling increases sensitivity toward oxidative stress in Escherichia coli. Metab Eng 29 (2015), 26–35 This paper demonstrates that metabolic futile cycling increases oxygen consumption and ROS production and decreases intracellular ATP. The net result is an intracellular phenotype similar to antibiotic-treated cells that exhibits increased sensitivity to oxidative stress.
54. Scott, M., Klumpp, S., Mateescu, E.M., Hwa, T., Emergence of robust growth laws from optimal regulation of ribosome synthesis. Mol Syst Biol, 10, 2014, 747.
55. Basan, M., Hui, S., Okano, H., Zhang, Z., Shen, Y., Williamson, J.R., Hwa, T., Overflow metabolism in Escherichia coli results from efficient proteome allocation. Nature 528 (2015), 99–104.
56. Levin, B.R., McCall, I.C., Perrot, V., Weiss, H., Ovesepian, A., Baquero, F., A numbers game: ribosome densities, bacterial growth, and antibiotic-mediated stasis and death. MBio, 8, 2017 This paper demonstrates that antibiotic lethality is associated with the number of functional ribosomal units for antibiotics inhibiting protein translation and that bacteriostatic antibiotics can be lethal in bacteria depleted for ribosomal operons.
57. Russell, J.B., Cook, G.M., Energetics of bacterial growth: balance of anabolic and catabolic reactions. Microbiol Rev 59 (1995), 48–62.
58. Liu, A., Tran, L., Becket, E., Lee, K., Chinn, L., Park, E., Tran, K., Miller, J.H., Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code. Antimicrob Agents Chemother 54 (2010), 1393–1403.
59. Nichols, R.J., Sen, S., Choo, Y.J., Beltrao, P., Zietek, M., Chaba, R., Lee, S., Kazmierczak, K.M., Lee, K.J., Wong, A., et al. Phenotypic landscape of a bacterial cell. Cell 144 (2011), 143–156.
60. Mathieu, A., Fleurier, S., Frenoy, A., Dairou, J., Bredeche, M.F., Sanchez-Vizuete, P., Song, X., Matic, I., Discovery and function of a general core hormetic stress response in E. coli induced by sublethal concentrations of antibiotics. Cell Rep 17 (2016), 46–57 This paper demonstrates that sublethal treatment with antibiotics of diverse classes induce a common, general stress response that increases metabolism and alters macromolecular physiological processes using a gene promoter–reporter system.
61. Alam, M.K., Alhhazmi, A., DeCoteau, J.F., Luo, Y., Geyer, C.R., RecA inhibitors potentiate antibiotic activity and block evolution of antibiotic resistance. Cell Chem Biol 23 (2016), 381–391.
62. Nautiyal, A., Patil, K.N., Muniyappa, K., Suramin is a potent and selective inhibitor of Mycobacterium tuberculosis RecA protein and the SOS response: RecA as a potential target for antibacterial drug discovery. J Antimicrob Chemother 69 (2014), 1834–1843.
63. Long, Q., Du, Q., Fu, T., Drlica, K., Zhao, X., Xie, J., Involvement of Holliday junction resolvase in fluoroquinolone-mediated killing of Mycobacterium smegmatis. Antimicrob Agents Chemother 59 (2015), 1782–1785.
64. Takahashi, N., Gruber, C.C., Yang, J.H., Liu, X., Braff, D., Yashaswini, C., Bhubhani, S., Furuta, Y., Andreescu, S., Collins, J.J., et al. Lethality of MalE–LacZ hybrid protein shares mechanistic attributes with oxidative component of antibiotic lethality. Proc Natl Acad Sci U S A 114 (2017), 9164–9169, 10.1073/pnas.1707466114 This paper investigates active death processes following stress response induction in an antibiotic-free system using a historically important fusion protein that shares several hallmarks with antibiotic lethality.
65. Storz, G., Hengge, R., American Society for Microbiology: Bacterial Stress Responses. edn 2, 2011, ASM Press.
66. Amato, S.M., Brynildsen, M.P., Persister heterogeneity arising from a single metabolic stress. Curr Biol 25 (2015), 2090–2098.
67. Radzikowski, J.L., Vedelaar, S., Siegel, D., Ortega, A.D., Schmidt, A., Heinemann, M., Bacterial persistence is an active sigmaS stress response to metabolic flux limitation. Mol Syst Biol, 12, 2016, 882 This paper integrated proteomic and metabolomic approaches to characterize persister phenotypes induced by nutrient transitions.
68. Kolpen, M., Mousavi, N., Sams, T., Bjarnsholt, T., Ciofu, O., Moser, C., Kuhl, M., Hoiby, N., Jensen, P.O., Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment. Int J Antimicrob Agents 47 (2016), 163–167.
69. Chevereau, G., Bollenbach, T., Systematic discovery of drug interaction mechanisms. Mol Syst Biol, 11, 2015, 807 This paper modeled the expected growth rate of E. coli single gene deletion mutants challenged with antibiotic combinations to identify genes and corresponding cellular functions involved in drug interactions.
70. Zemke, A.C., Kocak, B.R., Bomberger, J.M., Sodium nitrite inhibits killing of Pseudomonas aeruginosa biofilms by ciprofloxacin. Antimicrob Agents Chemother, 61, 2017.
71. Allison, K.R., Brynildsen, M.P., Collins, J.J., Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473 (2011), 216–220.
72. Bartek, I.L., Reichlen, M.J., Honaker, R.W., Leistikow, R.L., Clambey, E.T., Scobey, M.S., Hinds, A.B., Born, S.E., Covey, C.R., Schurr, M.J., et al. Antibiotic bactericidal activity is countered by maintaining pH homeostasis in Mycobacterium smegmatis. mSphere, 1, 2016.
73. Varik, V., Oliveira, S.R., Hauryliuk, V., Tenson, T., Composition of the outgrowth medium modulates wake-up kinetics and ampicillin sensitivity of stringent and relaxed Escherichia coli. Sci Rep, 6, 2016, 22308.
74. Bailey, A.M., Webber, M.A., Piddock, L.J., Medium plays a role in determining expression of acrB, marA, and soxS in Escherichia coli. Antimicrob Agents Chemother 50 (2006), 1071–1074.
75. Peng, B., Su, Y.B., Li, H., Han, Y., Guo, C., Tian, Y.M., Peng, X.X., Exogenous alanine and/or glucose plus kanamycin kills antibiotic-resistant bacteria. Cell Metab 21 (2015), 249–261.
76. Shan, Y., Lazinski, D., Rowe, S., Camilli, A., Lewis, K., Genetic basis of persister tolerance to aminoglycosides in Escherichia coli. MBio, 6, 2015.
77. Cote, J.P., French, S., Gehrke, S.S., MacNair, C.R., Mangat, C.S., Bharat, A., Brown, E.D., The genome-wide interaction network of nutrient stress genes in Escherichia coli. MBio, 7, 2016 This paper demonstrates that nutrient stress can yield synthetic lethal interactions with several metabolic processes.
78. Vilcheze, C., Hartman, T., Weinrick, B., Jain, P., Weisbrod, T.R., Leung, L.W., Freundlich, J.S., Jacobs, W.R. Jr., Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 114 (2017), 4495–4500 This paper demonstrates that metabolic amino acid supplementation may prevent the emergence of antibiotic resistance in M. tuberculosis.
79. Park, S., Imlay, J.A., High levels of intracellular cysteine promote oxidative DNA damage by driving the fenton reaction. J Bacteriol 185 (2003), 1942–1950.
80. Hartman, T., Weinrick, B., Vilcheze, C., Berney, M., Tufariello, J., Cook, G.M., Jacobs, W.R. Jr., Succinate dehydrogenase is the regulator of respiration in Mycobacterium tuberculosis. PLoS Pathog, 10, 2014, e1004510.
81. Brauner, A., Fridman, O., Gefen, O., Balaban, N.Q., Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol 14 (2016), 320–330.
82. Pu, Y., Zhao, Z., Li, Y., Zou, J., Ma, Q., Zhao, Y., Ke, Y., Zhu, Y., Chen, H., Baker, M.A., et al. Enhanced efflux activity facilitates drug tolerance in dormant bacterial cells. Mol Cell 62 (2016), 284–294.
83. Harms, A., Maisonneuve, E., Gerdes, K., Mechanisms of bacterial persistence during stress and antibiotic exposure. Science, 354, 2016 This is a good recent review on mechanisms of persister formation involving toxin–antitoxin systems and the stringent response.
84. Cohen, N.R., Lobritz, M.A., Collins, J.J., Microbial persistence and the road to drug resistance. Cell Host Microbe 13 (2013), 632–642.
85. Shan, Y., Brown Gandt, A., Rowe, S.E., Deisinger, J.P., Conlon, B.P., Lewis, K., ATP-dependent persister formation in Escherichia coli. MBio, 8, 2017 See annotation to Ref. [86].
86. Conlon, B.P., Rowe, S.E., Gandt, A.B., Nuxoll, A.S., Donegan, N.P., Zalis, E.A., Clair, G., Adkins, J.N., Cheung, A.L., Lewis, K., Persister formation in Staphylococcus aureus is associated with ATP depletion. Nat Microbiol, 1, 2016, 16051 These two papers [85,86] demonstrate that the formation of persister cells can be independent of toxin–antitoxin induction and depends on intracellular ATP levels.
87. Wu, M.L., Gengenbacher, M., Dick, T., Mild nutrient starvation triggers the development of a small-cell survival morphotype in Mycobacteria. Front Microbiol, 7, 2016, 947.
88. Vega, N.M., Allison, K.R., Khalil, A.S., Collins, J.J., Signaling-mediated bacterial persister formation. Nat Chem Biol 8 (2012), 431–433.
89. Vega, N.M., Allison, K.R., Samuels, A.N., Klempner, M.S., Collins, J.J., Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic tolerance. Proc Natl Acad Sci U S A 110 (2013), 14420–14425.
90. Verstraeten, N., Knapen, W.J., Kint, C.I., Liebens, V., Van den Bergh, B., Dewachter, L., Michiels, J.E., Fu, Q., David, C.C., Fierro, A.C., et al. Obg and membrane depolarization are part of a microbial bet-hedging strategy that leads to antibiotic tolerance. Mol Cell 59 (2015), 9–21.
91. Dorr, T., Vulic, M., Lewis, K., Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol, 8, 2010, e1000317.
92. Maisonneuve, E., Castro-Camargo, M., Gerdes, K., (p)ppGpp controls bacterial persistence by stochastic induction of toxin–antitoxin activity. Cell 154 (2013), 1140–1150.
93. Grimbergen, A.J., Siebring, J., Solopova, A., Kuipers, O.P., Microbial bet-hedging: the power of being different. Curr Opin Microbiol 25 (2015), 67–72.
94. Helaine, S., Cheverton, A.M., Watson, K.G., Faure, L.M., Matthews, S.A., Holden, D.W., Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science 343 (2014), 204–208.
95. Manina, G., Dhar, N., McKinney, J.D., Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms. Cell Host Microbe 17 (2015), 32–46.
96. Levin-Reisman, I., Ronin, I., Gefen, O., Braniss, I., Shoresh, N., Balaban, N.Q., Antibiotic tolerance facilitates the evolution of resistance. Science 355 (2017), 826–830.
97. Van den Bergh, B., Michiels, J.E., Wenseleers, T., Windels, E.M., Boer, P.V., Kestemont, D., De Meester, L., Verstrepen, K.J., Verstraeten, N., Fauvart, M., et al. Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence. Nat Microbiol, 1, 2016, 16020.
98. Artemova, T., Gerardin, Y., Dudley, C., Vega, N.M., Gore, J., Isolated cell behavior drives the evolution of antibiotic resistance. Mol Syst Biol, 11, 2015, 822.
99. Thompson, J.A., Oliveira, R.A., Djukovic, A., Ubeda, C., Xavier, K.B., Manipulation of the quorum sensing signal AI-2 affects the antibiotic-treated gut microbiota. Cell Rep 10 (2015), 1861–1871.
100. Lee, H.H., Molla, M.N., Cantor, C.R., Collins, J.J., Bacterial charity work leads to population-wide resistance. Nature 467 (2010), 82–85.
101. Yurtsev, E.A., Conwill, A., Gore, J., Oscillatory dynamics in a bacterial cross-protection mutualism. Proc Natl Acad Sci U S A 113 (2016), 6236–6241.
102. Meredith, H.R., Srimani, J.K., Lee, A.J., Lopatkin, A.J., You, L., Collective antibiotic tolerance: mechanisms, dynamics and intervention. Nat Chem Biol 11 (2015), 182–188.
103. Vega, N.M., Gore, J., Collective antibiotic resistance: mechanisms and implications. Curr Opin Microbiol 21 (2014), 28–34.
104. Bollenbach, T., Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution. Curr Opin Microbiol 27 (2015), 1–9.
105. Mitosch, K., Rieckh, G., Bollenbach, T., Noisy response to antibiotic stress predicts subsequent single-cell survival in an acidic environment. Cell Syst 4 (2017), 393–403.e5 This paper used a promoter–reporter screen to identify a temporal acid stress response to trimethoprim with implications for drug mechanism of action and antibiotic-induced cross-protection against other environmental stressors.
106. Pal, C., Papp, B., Lazar, V., Collateral sensitivity of antibiotic-resistant microbes. Trends Microbiol 23 (2015), 401–407.
107. Kim, S., Lieberman, T.D., Kishony, R., Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance. Proc Natl Acad Sci U S A 111 (2014), 14494–14499.
108. Imamovic, L., Sommer, M.O., Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med, 5, 2013, 204ra132.
109. Zampieri, M., Enke, T., Chubukov, V., Ricci, V., Piddock, L., Sauer, U., Metabolic constraints on the evolution of antibiotic resistance. Mol Syst Biol, 13, 2017, 917 This paper combined experimental evolution and metabolomics to characterize how metabolic fluxes shape bacterial adaptation to antibiotic stress.
110. Prideaux, B., Via, L.E., Zimmerman, M.D., Eum, S., Sarathy, J., O'Brien, P., Chen, C., Kaya, F., Weiner, D.M., Chen, P.Y., et al. The association between sterilizing activity and drug distribution into tuberculosis lesions. Nat Med 21 (2015), 1223–1227.
111. Pienaar, E., Cilfone, N.A., Lin, P.L., Dartois, V., Mattila, J.T., Butler, J.R., Flynn, J.L., Kirschner, D.E., Linderman, J.J., A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment. J Theor Biol 367 (2015), 166–179 This paper integrates spatially resolved mass spectrometry data with mathematical models of antibiotic susceptibility to predict treatment outcomes on the complex in vivo environments of M. tuberculosis granulomas.
112. Cameron, D.E., Collins, J.J., Tunable protein degradation in bacteria. Nat Biotechnol 32 (2014), 1276–1281.
113. Abel Zur Wiesch, P., Abel, S., Gkotzis, S., Ocampo, P., Engelstadter, J., Hinkley, T., Magnus, C., Waldor, M.K., Udekwu, K., Cohen, T., Classic reaction kinetics can explain complex patterns of antibiotic action. Sci Transl Med, 7, 2015, 287ra273 This paper demonstrates that simple mathematical models can explain several complex features of antibiotic killing dynamics.
114. Chandrasekaran, S., Cokol-Cakmak, M., Sahin, N., Yilancioglu, K., Kazan, H., Collins, J.J., Cokol, M., Chemogenomics and orthology-based design of antibiotic combination therapies. Mol Syst Biol, 12, 2016, 872 This paper applies a machine learning algorthim to chemogenomic screening data to predict outcomes from treatments with antibiotic combinations.
115. Wildenhain, J., Spitzer, M., Dolma, S., Jarvik, N., White, R., Roy, M., Griffiths, E., Bellows, D.S., Wright, G.D., Tyers, M., Prediction of synergism from chemical–genetic interactions by machine learning. Cell Syst 1 (2015), 383–395.
116. Aziz, R.K., Monk, J.M., Lewis, R.M., In Loh, S., Mishra, A., Abhay Nagle, A., Satyanarayana, C., Dhakshinamoorthy, S., Luche, M., Kitchen, D.B., et al. Systems biology-guided identification of synthetic lethal gene pairs and its potential use to discover antibiotic combinations. Sci Rep, 5, 2015, 16025.
117. Krueger, A.S., Munck, C., Dantas, G., Church, G.M., Galagan, J., Lehar, J., Sommer, M.O., Simulating serial-target antibacterial drug synergies using flux balance analysis. PLoS One, 11, 2016, e0147651.